AstraZeneca

AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing

AstraZeneca is establishing a new global strategic R&D centre in Beijing, its second in China and sixth worldwide Investment includes biotech agreements with Harbour BioMed, Syneron Bio and BioKangtai Press Release – 21 March 2025 – AstraZeneca today announced an investment of $2.5 billion in Beijing to establish its sixth global strategic R&D centre together with major research and manufacturing agreements that will further advance … Continue reading AstraZeneca to invest $2.5 billion in new global strategic R&D centre, biotech agreements and manufacturing in Beijing

Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer

Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer

Proven Pharmaceutical Executive Brings Over 30 Years of R&D Experience to Supercharge the Company’s Next Phase of Growth Seasoned Biotechnology Leader Mike Varney, Ph. D., Appointed as Lead Independent Director of the Board Press Release – SAN FRANCISCO, CALIFORNIA, FEBRUARY 18, 2025 – Atomwise, a leader in leveraging machine learning and artificial intelligence (ML/AI) to advance small molecule drug discovery, today announced the appointment of Steve … Continue reading Atomwise Appoints Steve Worland, Ph.D. as Chief Executive Officer

Jean-Charles Wirth

New CEOs for Life Science and Healthcare business sectors and New Chief People Officer

The Board of Partners of E. Merck KG has appointed three new members to the Executive Board of Merck KGaA. Press Release – 18 Feb 2025 | Darmstadt, Germany Darmstadt, Germany, February 18, 2025 – The Board of Partners of E. Merck KG has appointed three new members to the Executive Board of Merck KGaA – a natural evolution in the company’s leadership as it continues to … Continue reading New CEOs for Life Science and Healthcare business sectors and New Chief People Officer

Wedgewood Appoints Stanley Howell as Chief Operations Officer

Wedgewood Appoints Stanley Howell as Chief Operations Officer to Drive Growth and Operational Excellence

Press Release – February 06, 2025 – SWEDESBORO, N.J. – Wedgewood, the nation’s largest provider of compounded veterinary medications and pharmacy solutions, has appointed Stanley Howell as Chief Operations Officer. Howell brings extensive expertise in operations, strategy, and supply chain excellence, reinforcing Wedgewood’s commitment to innovation, efficiency, and best-in-class service for veterinary professionals. Howell’s appointment comes at a pivotal time as Wedgewood builds upon the momentum from VMX … Continue reading Wedgewood Appoints Stanley Howell as Chief Operations Officer to Drive Growth and Operational Excellence

AstraZeneca

AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery

Press Release – 23 January 2025 700 new scientific and high-skilled jobs to be created in Greater Toronto Area, investing to execute more than 210 AstraZeneca global clinical studies AstraZeneca, a global pharmaceutical company focused on developing life changing medicines, today announced a C$820 million (US$570m) investment in Canada, creating more than 700 high-skilled jobs, across all areas of the business. The investment will support … Continue reading AstraZeneca plans C$820 million (US$570m) investment in Canada to advance growing global hub and clinical delivery